Bookimed does not add extra charges for Immunotherapy prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your Immunotherapy upon your arrival.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
| The USA | Turkey | Mexico | |
| Sarcoma Immunotherapy | from $10800 | from $3600 | from $4140 |
| Immunotherapy for prostate cancer | from $30000 | from $10000 | from $11500 |
| Immunotherapy for lung cancer | from $30000 | from $10000 | from $11500 |
| Immunotherapy for kidney cancer | from $30000 | from $10000 | from $11500 |
| Immunotherapy for breast cancer | from $30000 | from $10000 | from $11500 |
The therapy is a treatment enhancing the body"s immune system to fight cancer, using a drug highly targeted and effective.
This therapy modifies patient"s cells to combat cancer, merging immunology and genetics. It"s precise, powerful, potentially one-off treatment.
Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
What patients like:
What patients don't like:
This doctor has experience in endocrine treatment, collaborating on studies aimed at overcoming resistance to hormone therapy. They have also been involved in numerous phase 1, 2 and 3 studies in breast and melanoma, which have led to the approval of new drugs in new indications. Their main area of interest lies in immunotherapy for melanoma treatment and patient care. They have participated in trials that have led to the approval of cdk4/6 palbociclib and ribociclib inhibitors in the first line of metastatic breast cancer, and Pembrolizumab in the first line of metastatic melanoma, as well as the combination of Nivolumab and Ipilimumab. They are a member of the Breast Cancer Unit and Melanoma Unit at the Vall d'Hebron University Hospital and the Vall d'Hebron Institute of Oncology. This doctor is an experienced oncologist with expertise in breast cancer and melanoma treatments, including endocrine therapy, immunotherapy, and patient care. They have been involved in numerous clinical trials leading to the approval of new drugs in new indications.
Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.
Doctor is a Medical Oncologist with expertise in angiogenesis, DNA repair mechanisms, and immunology. She has a degree in medicine from Complutense University of Madrid, a medical oncology MD from the same university, and a PhD from Univesidad Autonoma de Barcelona. She is a Co-Chair of the GEICO Group, Faculty member for the Gyn-Track in the European Society of Medical Oncology, Spanish Representative of GOG, Spanish representative in the Cervical Committee and Phase II Committee of the GCIG Group, and an active member of the American Society of Clinical Oncology, European Society of Medical Oncology, and the Spanish Association of Medical Oncology. She has authored over 100 publications and presentations.
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
CAR T-cell therapy is a personalized immune system therapy that modifies a patient's T-cells to target and destroy cancer cells.